Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Times of Israel.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on June 9, 2025
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
GlobeNewswire
·
June 9, 2025
In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 trial of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal colorectal surgery patients with large incisions. The …
SaverOne Further Broadens its Global Expansion with a new Agreement with CEMEX Germany
GlobeNewswire
·
June 9, 2025
The expansion Continues CEMEX Rollout of SaverOne’s Safety Systems Across its Global Operations Petah Tikvah, Israel, June 09, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in developing …
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints
GlobeNewswire
·
June 9, 2025
D-PLEX100 successfully met the primary efficacy endpoint, with statistically significant results (p<0.005) in 798 patients with large abdominal surgery incisions. The trial successfully met all key secondary efficacy endpoints, including a 58% reduction in …
Alarum Technologies Updates Second Quarter 2025 Revenue and Adjusted EBITDA Outlook
GlobeNewswire
·
June 9, 2025
TEL AVIV, Israel, June 09, 2025 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of web data collection solutions, today announced an update to its revenue and Adjusted EBITDA outlook for the …
Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030
GlobeNewswire
·
June 9, 2025
As of March 31, 2025, ODDITY had $257 million in cash, and an undrawn $200 million credit line Capital raise gives ODDITY additional firepower to play offense and pursue future opportunities in a volatile world A portion of the proceeds will be used to …
REE Announces Cost Reduction Measures to Sustain Long-Term Growth
GlobeNewswire
·
June 9, 2025
Initiated cost reduction measures targeting a 55% decrease in operating costs to a projected average of approximately $2.7 million per month by year-end related to pause in production and an approximately 50% reduction-in-force The company aims to extend …